A set of chameleon-like immune cells could be contributing to severe asthma in some patients. Intermediate group 2 innate lymphoid cells (ILC2s) appear to be able to get around cutting-edge asthma treatments by transforming into another type of immune cell. Targeted biologic drugs have revolutionized the treatment of severe asthma driven by eosinophils, which are… read on > read on >



















